The 2021 MedTech Contract Manufacturing Report

Published March 2021 | 23 Pages | Forecasts Through 2021

Request Info

Order individually or subscribe and get a complete intel platform.


This is a special report produced by Alira Health in collaboration with LSI & MassMEDIC.  This analysis leverages public data and primary research including multiple survey with Contract Development and Manufacturing Organizations (CDMOs) and interviews with industry executives. Despite experiencing vulnerability to the pandemic, the medical device and CDMO industries are positioned to perform strongly in 2021. 

Year in Review
Cardiovascular, orthopedics and imaging were the most impacted sectors in 2020, as opposed to in-vitro diagnostics, critical and respiratory care and hospital consumables, whose demand got a boost from the new hospital protocols.

Impact of COVID-19
The healthcare emergency has required hospitals to prioritize treatment and prevention of COVID-19 patients during all of 2020 and into Q1 of 2021. This has caused a dramatic decline in volumes of elective procedures, with a large impact on the global industry revenue.

Revenue Impact to Top Global Medtech Companies
The COVID effect on the medical device industry is visible in the performance of the largest OEMs. Businesses more oriented to elective procedures suffered declining sales in 2020. Others, active in the markets for diagnostics and treatment of COVID-19, had a revenue boost.

Get complete details on the Global Medtech Contract Manufacturing Market by accessing this special report.

Companies Covered




Boston Scientific

GE Healthcare

Johnson & Johnson



Roche Diagnostics

Siemens Healthineers


Ready to get started?

We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.